Interaction between Angiotensin Receptor and β-Adrenergic Receptor Regulates the Production of Amyloid β-Protein.
Adrenergic beta-Antagonists
/ pharmacology
Amyloid beta-Peptides
/ metabolism
Angiotensin II Type 1 Receptor Blockers
/ pharmacology
Animals
Atenolol
/ pharmacology
Bisoprolol
/ pharmacology
Cells, Cultured
Mice, Inbred C57BL
Propanolamines
/ pharmacology
Propranolol
/ pharmacology
Receptor, Angiotensin, Type 1
/ metabolism
Receptors, Adrenergic, beta-2
/ metabolism
Telmisartan
/ pharmacology
Alzheimer’s disease
adrenergic receptor
amyloid β-protein
angiotensin receptor
Journal
Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
1
12
2020
Statut:
ppublish
Résumé
Alzheimer's disease (AD) is characterized by the formation of extracellular amyloid plaques containing the amyloid β-protein (Aβ) within the parenchyma of the brain. Aβ is considered to be the key pathogenic factor of AD. Recently, we showed that Angiotensin II type 1 receptor (AT
Identifiants
pubmed: 32238715
doi: 10.1248/bpb.b20-00007
doi:
Substances chimiques
Adrenergic beta-Antagonists
0
Amyloid beta-Peptides
0
Angiotensin II Type 1 Receptor Blockers
0
Propanolamines
0
Receptor, Angiotensin, Type 1
0
Receptors, Adrenergic, beta-2
0
ICI 118551
46OL1UC10R
Atenolol
50VV3VW0TI
Propranolol
9Y8NXQ24VQ
Telmisartan
U5SYW473RQ
Bisoprolol
Y41JS2NL6U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM